Clinical Trials Directory

Trials / Conditions / Advanced Non-Small Cell Squamous Lung Cancer

Advanced Non-Small Cell Squamous Lung Cancer

7 registered clinical trials studyying Advanced Non-Small Cell Squamous Lung Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingEmulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic He
NCT07485166
Brigham and Women's Hospital—
RecruitingWhole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
NCT06222489
The Netherlands Cancer InstitutePhase 2
RecruitingPrimary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemot
NCT06037733
Hubei Cancer HospitalN/A
Active Not RecruitingHER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease
NCT05865990
MedSIRPhase 2
TerminatedClinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
NCT05652868
Mythic TherapeuticsPhase 1
Active Not RecruitingPhase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With E
NCT05256290
Black Diamond Therapeutics, Inc.Phase 1 / Phase 2
UnknownSintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
NCT04846452
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2